{"id":447146,"title":"Canada Gazette Part I - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T13:42:49.515000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/legislation-guidelines/canada-gazette-part-1.html?wbdisable=false","snippet":"Canada Gazette Part I The following proposed regulatory amendments and Regulatory Impact Analysis Statement ( RIAS ) were recently pre-published in the Canada Gazette Part I for public consultation. Readers are invited to provide comments on these proposals within the time period…","rawSnapshotUrl":"/api/snapshots/raw/447146","browseUrl":"https://replay.healtharchive.ca/job-6/20260103134249/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/legislation-guidelines/canada-gazette-part-1.html?wbdisable=false#ha_snapshot=447146","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}